Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Lally

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Schizophrenia Research|September 25, 2013
Vitamin D deficiency in first episode psychosis: a case-control studyMatthieu Crews, John Lally, Poonam Gardner-Sood, et al.
NPJ Schizophrenia|June 24, 2016
Does environmental confounding mask pleiotropic effects of a multiple sclerosis susceptibility variant on vitamin D in psychosis?Conrad O Iyegbe, Anita Acharya, John Lally, et al.
Schizophrenia Research|May 26, 2018
Predictors of falls and fractures leading to hospitalization in people with schizophrenia spectrum disorder: A large representative cohort studyBrendon Stubbs, Christoph Mueller, Fiona Gaughran, et al.
Journal of Clinical Psychopharmacology|April 25, 2017
Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor: A Systematic ReviewJohn Lally, Steffi Malik, Eromona Whiskey, et al.
Journal of Clinical Psychopharmacology|August 18, 2017
The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic ReviewJohn Lally, Steffi Malik, Amir Krivoy, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|June 7, 2016
Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysisDavy Vancampfort, Christoph U Correll, Britta Galling, et al.
Investigative Ophthalmology & Visual Science|September 24, 2013
The TFOS International Workshop on Contact Lens Discomfort: report of the contact lens materials, design, and care subcommitteeLyndon Jones, Noel A Brennan, José González-Méijome, et al.
Schizophrenia Research|September 14, 2021
Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controlsShuichi Suetani, Faraz Honarparvar, Dan Siskind, et al.
Psychopharmacology|August 25, 2018
Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophreniaGrant McQueen, John Lally, Tracy Collier, et al.
BMC Medicine|November 23, 2016
Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countriesBrendon Stubbs, Ai Koyanagi, Nicola Veronese, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Schizophrenia Research|September 25, 2013
Vitamin D deficiency in first episode psychosis: a case-control studyMatthieu Crews, John Lally, Poonam Gardner-Sood, et al.
NPJ Schizophrenia|June 24, 2016
Does environmental confounding mask pleiotropic effects of a multiple sclerosis susceptibility variant on vitamin D in psychosis?Conrad O Iyegbe, Anita Acharya, John Lally, et al.
Schizophrenia Research|May 26, 2018
Predictors of falls and fractures leading to hospitalization in people with schizophrenia spectrum disorder: A large representative cohort studyBrendon Stubbs, Christoph Mueller, Fiona Gaughran, et al.
Journal of Clinical Psychopharmacology|April 25, 2017
Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor: A Systematic ReviewJohn Lally, Steffi Malik, Eromona Whiskey, et al.
Journal of Clinical Psychopharmacology|August 18, 2017
The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic ReviewJohn Lally, Steffi Malik, Amir Krivoy, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|June 7, 2016
Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysisDavy Vancampfort, Christoph U Correll, Britta Galling, et al.
Investigative Ophthalmology & Visual Science|September 24, 2013
The TFOS International Workshop on Contact Lens Discomfort: report of the contact lens materials, design, and care subcommitteeLyndon Jones, Noel A Brennan, José González-Méijome, et al.
Schizophrenia Research|September 14, 2021
Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controlsShuichi Suetani, Faraz Honarparvar, Dan Siskind, et al.
Psychopharmacology|August 25, 2018
Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophreniaGrant McQueen, John Lally, Tracy Collier, et al.
BMC Medicine|November 23, 2016
Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countriesBrendon Stubbs, Ai Koyanagi, Nicola Veronese, et al.
Pageof 10